Hearing News Watch

Featured image for “Otolith Labs Study Demonstrates Effectiveness of Vestibular Stimulation Technology in Reducing Cybersickness from Virtual Reality”
Feb. 14, 2025

Otolith Labs Study Demonstrates Effectiveness of Vestibular Stimulation Technology in Reducing Cybersickness from Virtual Reality

HHTM
WASHINGTON, D.C. – Otolith Labs, a medical technology company developing prescription medical devices for vestibular disorders, has announced findings from an exploratory user study evaluating the impact of vestibular stimulation technology on cybersickness during virtual reality (VR) experiences. The study results indicate that subjects using Otolith technology reported lower nausea levels and longer VR engagement durations compared to those without
Featured image for “Amplifon Marks Valentine’s Day with “Endless Love” Campaign Highlighting the Importance of Hearing Well”
Feb. 14, 2025

Amplifon Marks Valentine’s Day with “Endless Love” Campaign Highlighting the Importance of Hearing Well

HHTM
MILAN, ITALY – Amplifon, a global leader in hearing care solutions and parent company of Miracle-Ear, has launched “Endless Love,” a special communication initiative for Valentine’s Day. The campaign emphasizes the role of hearing well in maintaining meaningful relationships and experiencing emotions fully. The campaign features an image of a senior couple walking and embracing, accompanied by the message: “The
Featured image for “Stanford and Starkey Collaborate on Study Validating Balance Assessment for Fall Risk Detection in Hearing Aids”
Feb. 13, 2025

Stanford and Starkey Collaborate on Study Validating Balance Assessment for Fall Risk Detection in Hearing Aids

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey has collaborated with researchers at Stanford University to evaluate its Balance Assessment feature, a technology available with Edge AI. A recent peer-reviewed study, published in Otology & Neurotology, examines the findings of this research, contributing to the ongoing exploration of balance assessment in hearing technology. Falls are a leading cause of injury among older adults,
Featured image for “AudioCure Pharma Secures Funding from InfectoPharm to Accelerate Clinical Trials for AC102”
Feb. 13, 2025

AudioCure Pharma Secures Funding from InfectoPharm to Accelerate Clinical Trials for AC102

HHTM
HEPPENHEIM & BERLIN, GERMANY – There is currently no globally approved drug for the treatment of sudden hearing loss, a condition that affects thousands of individuals each year. However, AudioCure Pharma, a Berlin-based biopharmaceutical company, is advancing research on AC102, an innovative drug candidate that has shown promising results in preclinical and Phase 1 clinical studies. In a significant development,
Featured image for “The AAA Foundation Jill Botkin Hearing Health-Care Accessibility Scholarship, Sponsored by HearUSA, is Now Open for Applications”
Feb. 12, 2025

The AAA Foundation Jill Botkin Hearing Health-Care Accessibility Scholarship, Sponsored by HearUSA, is Now Open for Applications

HHTM
Palm Beach Gardens, FLORIDA, January 30, 2025 — Leading hearing care retailer HearUSA today announced that the 2025 American Academy of Audiology Foundation Jill Botkin Hearing Health-Care Accessibility Scholarship is now open for nominations. The annual scholarship was created last year in memory of thirty-five year HearUSA employee Jill Botkin, who passed away in 2023. The program is open for applications
Featured image for “Amplifon Marks 75 Years with New Podcast Exploring Its History”
Feb. 12, 2025

Amplifon Marks 75 Years with New Podcast Exploring Its History

HHTM
MILAN, ITALY — “A Sound Idea”, a new podcast produced by Amplifon in collaboration with Italian podcast production company Chora Media, is now available. The podcast, released in both Italian and English, explores the 75-year history of Amplifon, the world’s leading provider of hearing care services and solutions. The episode recounts the company’s origins, beginning in a basement in downtown
Featured image for “Oticon Now Accepting Nominations for 2025 Oticon Focus on People Awards”
Feb. 12, 2025

Oticon Now Accepting Nominations for 2025 Oticon Focus on People Awards

HHTM
SOMERSET, NEW JERSEY — Oticon, Inc. is now accepting nominations for the 2025 Oticon Focus on People Awards. It is Oticon’s long-standing national program celebrating individuals with hearing loss and the caregivers, educators and professionals who champion their success. This year, the awards will honor three exceptional hearing champions: those who are stamping out stereotypes, advancing care, inclusion and awareness;
Featured image for “Cilcare’s SAPHIR Study Explores Role of Hearing in Early Alzheimer’s and Parkinson’s and Identify New Auditory Biomarkers”
Feb. 10, 2025

Cilcare’s SAPHIR Study Explores Role of Hearing in Early Alzheimer’s and Parkinson’s and Identify New Auditory Biomarkers

HHTM
MONTPELLIER, FRANCE – Cilcare, a biotechnology company specializing in auditory sciences, has announced the launch of the SAPHIR study (early Stage of Alzheimer’s and Parkinson’s diseases, HearIng Relevance), an observational clinical study examining the relationship between hearing impairments and neurodegenerative diseases, particularly in the early stages of mild cognitive impairment (MCI) and Parkinson’s disease. Conducted in partnership with the University
Featured image for “Fennec Pharmaceuticals Announces Launch of PEDMARQSI® in Germany by Norgine”
Feb. 08, 2025

Fennec Pharmaceuticals Announces Launch of PEDMARQSI® in Germany by Norgine

HHTM
RESEARCH TRIANGLE PARK, N.C. — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, has announced that Norgine Pharmaceuticals Ltd., a European specialist pharmaceutical company, has commercially launched PEDMARQSI® (sodium thiosulfate injection) in Germany. Licensing Agreement and Market Expansion In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI® in Europe, Australia,
Featured image for “EUHA Opens Applications for 2025 Sponsorship Award to Recognize Emerging Talent in Hearing Acoustics”
Feb. 07, 2025

EUHA Opens Applications for 2025 Sponsorship Award to Recognize Emerging Talent in Hearing Acoustics

HHTM
MUNSTER, GERMANY – The European Union of Hearing Aid Acousticians (EUHA) has announced the call for entries for the 2025 EUHA Sponsorship Award. Now in its 15th year, the award recognizes outstanding academic work in audiology, hearing aid fitting, and customer benefits. Applications will be accepted until August 15, 2025. “The aim of the EUHA Sponsorship Award is to promote